Eosinophilic esophagitis
Diagnosis and newer treatments, including biologics, for eosinophilic esophagitis.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 25, 18, 18, 19, 14.
New guidelines and consensus this year
- American Society for Gastrointestinal Endoscopy consensus recommendations on the endoscopic management of eosinophilic esophagitis-part 2: disease assessment, monitoring, and pediatric considerationsGastrointest Endosc2026 Mar
- BRAZILIAN GASTROENTEROLOGY FEDERATION (FBG) CLINICAL GUIDELINE: DIAGNOSIS AND TREATMENT OF EOSINOPHILIC ESOPHAGITIS IN ADULTS AND ADOLESCENTSArq Gastroenterol2025
All papers from the last 12 months
507 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Lymphocytic Esophagitis Mimicking Eosinophilic Esophagitis and Esophageal Candidiasis: A Case ReportDEN Open2027 AprPMID 42465714
- Ulcerative Esophagitis With Marked Eosinophilic Infiltration and Fluorodeoxyglucose-Positron Emission Tomography Positivity Requiring Differentiation From Esophagogastric Junction CarcinomaDEN Open2027 AprPMID 42416861
- Localized delivery of budesonide via mucoadhesive short nanofibers for Eosinophilic esophagitis (EoE) therapyInt J Pharm2026 Nov 5PMID 42710750
- Monoclonal Antibody Therapy in Eosinophilic Esophagitis: A Narrative Review of Effects on Dysphagia, Histologic Response, and Endoscopic OutcomesJ Clin Gastroenterol2026 Oct 16PMID 42881493
- Emerging data of use of biologics in eosinophilic esophagitis in childrenPediatr Res2026 Oct 15PMID 42881262
- Methodological Considerations in Interpreting Dairy-Free Diet Efficacy in Adult Eosinophilic OesophagitisJ Gastroenterol Hepatol2026 Oct 14PMID 42875823
- Letter: Moving Beyond the Biopsy in Eosinophilic Esophagitis: A Goal, but Not Yet a RealityAliment Pharmacol Ther2026 Oct 14PMID 42875733
- Distinct molecular effects of vonoprazan and proton pump inhibitors in eosinophilic esophagitisAllergol Int2026 Oct 14PMID 42875292
- Diffuse esophageal eosinophilia is associated with increased endoscopic severity and topical steroid non-response in patients with eosinophilic esophagitisClin Gastroenterol Hepatol2026 Oct 12PMID 42863780
- Dupilumab Improves Esophageal Distensibility in EoE: 24-Week Results From the REMODEL Randomized TrialAm J Gastroenterol2026 Oct 12PMID 42861971
More gastroenterology trends
All specialties →Third-space endoscopy
Peroral endoscopic myotomy and endoscopic submucosal dissection.
Potassium-competitive acid blockers
Vonoprazan and related acid suppressants.
AI in colonoscopy
Computer-aided polyp detection and characterisation during colonoscopy.
Metallic vs plastic biliary stents
Studies comparing metallic and plastic stents for biliary obstruction.
Blood and stool tests for colorectal cancer screening
Blood-based and multitarget stool tests for colorectal cancer screening.
Key point: Next-generation mt-sDNA and mt-sRNA are preferred 3-year stool options; blood-based tests should be recommended only when preferred screening tests are declined or incomplete.
JAK inhibitors in IBD
Upadacitinib, tofacitinib and filgotinib in inflammatory bowel disease.
Key point: Tofacitinib and filgotinib are efficacious in ulcerative colitis, and upadacitinib is efficacious in both ulcerative colitis and Crohn’s disease.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"eosinophilic esophagitis"[tiab] OR "eosinophilic oesophagitis"[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.